openPR Logo
Press release

Global Injectable Nanomedicines Market growing at a CAGR of 7.3% during (2018-2025)-GMI Research

06-04-2019 01:33 PM CET | Health & Medicine

Press release from: GMI Research

Global Injectable Nanomedicines Market growing at a CAGR of 7.3%

The global injectable nanomedicines market touched USD 479.6 million in 2017, and is expected to reach USD 833.9 million by 2025, growing at a CAGR of 7.3% during 2018–2025.

Source: GMI Research

Major Factors driving the market growth are:
· Growing incidence of chronic diseases like cancer, cardiovascular diseases, neurological disorders
· Increasing research & development activities and clinical trials
· Rising demand and adoption of minimally invasive treatments
· Rising government and private funding
· Increasing geriatric population

Growing demand for minimal invasive treatments is driving the Injectable Nanomedicines market. Introduction of innovative and advanced nanotechnology and nanomedicines, especially in the emerging markets with the help of government and private funding would spur the growth of market for the injectable nanomedicines during the forecast period.

Request Sample @ https://tinyurl.com/y2anq5dq

A paradigm shifts from traditional therapeutics to novel therapeutics using nanomedicines is propelling the overall market as nanomedicines have higher payload capacity, prolonged blood circulation times, reduced toxicity and improved anti-tumour efficacy. Moreover, the application of injectable nanomedicines for some widespread chronic diseases like migraine and depression is also aiding market growth. The use of injectable nanomedicines are found to be efficient, lasting and easy treatment of many chronic cardiovascular and neurological disorders.

Growing incidence rate due to aging demographic patterns and the extension of health insurance coverage in a developing region will support the market growth. Advancements in cancer drug delivery and personalized cancer treatments, effective and safe treatment of medically refractory movement disorders and the need for fast and efficient cardiovascular systems will primarily drive the global injectable nanomedicine market.

“The rising pool of patients of chronic diseases and the need for a fast, efficient and long-lasting treatment with minimal invasion procedures will drive the injectable nanomedicines market.”
—-GMI Research

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Request for Customization : https://tinyurl.com/y342k6as

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Key takeaways/key essentials:
· In 2017, the cancer treatment held the major share for the injectable nanomedicines market followed by the cardiovascular diseases segment.
· High demand and adoption rate for minimally invasive treatments in the recent past.
· Extended research and development activities are taking place using the injectable nanomedicines regarding the concept of targeted drug delivery system.

Some of the key players operating in the global market for injectable nanomedicines include Merck & Co., Inc., Lupin, Pacira Pharmaceuticals Inc., Celgene Pharmaceutical Co. Ltd., Amgen, Inc., Janssen Biotech Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Inc. among others.

The global injectable nanomedicines market has been segmented based on product type, indication type and key geographies. Based on the product type, global injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals and others. Based on indication type, the market has been segmented into cancers, central nervous system diseases, cardiovascular diseases, inflammatory diseases and others.

The research report “global injectable nanomedicines market” provides in-depth analysis of injectable nanomedicines market, globally, based on product type, indication and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fuelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for injectable nanomedicines market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

Contact Sarah Nash
Tel: +353 1 536 3035
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Injectable Nanomedicines Market growing at a CAGR of 7.3% during (2018-2025)-GMI Research here

News-ID: 1763776 • Views:

More Releases from GMI Research

OLED Market is projected to rise at a higher CAGR during the forecast period | S …
The OLED Market is anticipated to expand at a remarkable CAGR during the forecast period For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-oled-market/ The factors driving growth of the OLED Market includes increasing penetration of smartphones and gaming consoles around the world, Government policies supporting OLED lighting research, growing popularity of smart Televisions and improvements in the living standards. For instance, the revenue generated from the sales of video game consoles
3D Printed Drugs Market is growing at a CAGR of 4.2% over the forecast period | …
The 3D Printed Drugs Market is growing at a CAGR of 4.2% over the forecast period. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/ The factors driving growth of the 3D Printed Drugs Market includes increasing geriatric population around the world, growing demand for soluble drugs, rising prevalence of stroke, Alzheimer's disease and head and neck tumors and improvements in the living standards. For instance, the population aged 60 and
Virtual Private Cloud Market is expected to grow at a higher CAGR of 23.4% over …
The Virtual Private Cloud Market is projected to grow at a CAGR of 23.4% over the forecast period. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-virtual-private-cloud-market/ The factors driving growth of the Virtual Private Cloud Market includes huge volumes of data generated across BSFI, Healthcare and Media & Entertainment industries, rising focus by companies on modernizing IT infrastructure, Government initiatives promoting digitalization, increasing number of data breaches reported around the
Pest Control Services Market is poised to grow at a robust CAGR during the forec …
The Pest Control Services Market is estimated to grow at a robust CAGR over the forecast period For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/pest-control-services-market/  The factors driving growth of market includes increasing demand for pest control services from hospitality, pharmaceutical, and food processing industries, growing focus on using biocides, rising concerns related to climate change, and improvements in the living standards. For instance, the market value of biocides worldwide was

All 5 Releases


More Releases for CAGR

Cat Litter Box Market | CAGR of 9.1% | Revenue & CAGR of 9.1%
Cat Litter Box Market Report provides precise data about the market size, commercialization aspects and revenue forecast of the industry. The global Cat Litter Box market offers a historical factsheet relevant to the strategic mergers, acquirements, joint venture activities, and partnerships spread in the Cat Litter Box market. The most advanced data has been presented in the study on the revenue numbers, product details, and sales of the major firms.
Predictive Analytics Market Growing at Strong CAGR of CAGR of 25.31% 2019
Predictive analytics helps to extract information from the existing data. It helps in understanding the pattern and predict the trend or future for the organization. It uses what-if scenarios to predict possible risks involved in the future. Predictive analytics also helps in the optimization of the marketing campaigns and understanding of the customer behaviour for increasing the end-user response and to reduce the churn. Predictive analytics is segmented into: Risk management:
Global Absorption Chillers Market Reflecting a CAGR of 7.6% CAGR through 2025
The demand for thermally-driven chillers in multiple industrial verticals is poised to grow in the immediate future. Considering the rising demand for electrical chillers in commercial, residential as well as industrial settings, the adoption of absorption chillers will gain traction at considerable rate. By consuming lesser energy than conventional electrical chillers, absorption chillers will also garner surplus demand for not using ozone-depleting chlorofluorocarbons (CFC) for chilling purposes. Persistence Market Research’s
Aircraft Sensors Market Growing at a CAGR of 6.4% CAGR By 2022
The global aircraft sensors market is forecasted to receive a strong push in its growth momentum on the back of advancements in technologies, massive investments forwarded by private equity groups, and the elevation in the demand for aircraft. Adherence to the requirements and regulations of authorities such as local aircraft regulatory bodies and the Federal Aviation Administration (FAA) could pamper the growth of the market. Nonetheless, there could be more
China Baby Diapers Market Reflecting a CAGR of 19.1% CAGR 2012-2017
The increasing birth rate in China has proven to be a boon for the country’s baby diaper’s market. To provide a comprehensive analysis of the growth trajectory exhibited by the China baby diapers market and study the impact of the dynamic regulatory policies on the market, Transparency Market Research (TMR) has published a report, titled “Baby Diapers Market - China Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012
Ecg Device Market Register a CAGR Growth of 4.1% CAGR by 2024
This region holds highest market share over the forecast period (2016-2024) and is expected to exhibit slow growth rate. The Asia Pacific is expected to be the fastest-growing region for ECG devices owing to its increasing incidence rate of cardiovascular diseases and high population. ECG devices are experiencing a paradigm technological shift from resting ECG systems to portable Holter monitoring systems, owing to their advantages of patient mobility, low prices and